AMED
$236.43
Amedisys
$4.39
1.89%
AMED
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.27
Revenue:  $533.09 Mil
Tuesday
Oct 27
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AMED reports earnings?
Beat
Meet
Miss

Where is AMED's stock price going from here?
Up
Flat
Down
Stock chart of AMED
Analysts
Summary of analysts' recommendations for AMED
Score
Grade
Pivots
Resistance
$249.37
$244.52
$240.48

$235.63

Support
$231.59
$226.74
$222.70
Tweet
Growth
Description
Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. They work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs.
Peers
HumanaChemed